lipoprotein compositional analysis showed that estrogen administration caused significant increases in all vldl and hdl constituents ( protein , cholesterol , phospholipid , and triglyceride ) as well as vldl apolipoprotein ( apo ) b ( 118.9 % increase ) and hdl apoa-i ( 27.4 % increase ) .
C0023820
lipoprotein
C0023825
vldl